Consumer medicine information

Montelair 10 mg Tablets

Montelukast

BRAND INFORMATION

Brand name

Montelair

Active ingredient

Montelukast

Schedule

S4

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Montelair 10 mg Tablets.

What is in this leaflet


This leaflet answers some common questions about Montelair. It does not contain all the available information.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you taking Montelair against the benefits they expect it will have for you.
If you have any concerns about taking this medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine.
You may need to read it again.

What Montelair is used for


Montelair is used to prevent asthma symptoms, including those that occur during the day and at night-time. It also prevents the narrowing of airways triggered by exercise.
If you have seasonal allergic rhinitis (hay fever), Montelair also treats your allergic rhinitis symptoms.
It can be used in children 2 years of age and older, teenagers and adults.
Montelair are not used to treat an acute attack of asthma. If an acute attack occurs, follow your doctor's instructions for your reliever medicine, and keep taking your Montelair each night or as prescribed.
As a preventive medicine for asthma, Montelair can be used alone or in combination with other preventive medicines, such as inhaled corticosteroids. Your doctor may reduce your dose of inhaled corticosteroid while you are taking Montelair.
Asthma is a lung disease and has the following characteristics:

  • narrowed airways causing breathing to become difficult
  • inflamed airways, which means the lining of airways become swollen
  • sensitive airways that react to many things, such as cigarette smoke, pollen, or cold air.

Symptoms of asthma include coughing, wheezing and chest tightness. Not all people with asthma wheeze. For some, coughing may be the only symptom of asthma. Symptoms often occur during the night or after exercise.
For further information about asthma, contact the Asthma Foundation in your state on 1800 645 130, or www.asthmaaustralia.org.au
Seasonal allergic rhinitis (also known as hay fever) is an allergic response often caused by airborne pollens from trees, grasses, and weeds. The daytime and nighttime symptoms of seasonal allergic rhinitis typically may include: stuffy, runny, itchy nose; sneezing; watery, swollen, red, itchy eyes.

How Montelair works


Montelair belongs to a group of medicines called leukotriene receptor antagonists. It works by blocking substances in your lungs called leukotrienes that cause narrowing and swelling of airways. Blocking leukotrienes improves asthma symptoms and helps prevent asthma attacks. Leukotrienes also cause allergic rhinitis symptoms. By blocking leukotrienes, Montelair improves seasonal allergic rhinitis symptoms.
Your doctor may have prescribed Montelair for another reason. Ask your doctor if you have any questions about why Montelair has been prescribed for you.
Montelair is not addictive.

Before You Take Montelair

When you must not take it


Do not take Montelair if:
• you have an allergy to Montelair or any of the ingredients listed at the end of this leaflet
• the packaging is torn or shows signs of tampering
• the expiry date on the pack has passed.
If you take this medicine after the expiry date has passed, it may not work.
If you are not sure whether you should start taking Montelair, talk to your doctor.
Do not give Montelair to children under 2 years of age.
Safety and effectiveness in children younger than 2 years of age have not been studied.
In studies investigating the effect of Montelair on the growth rate of children, it was shown that Montelair did not affect the growth rate of children when given for up to 56 weeks in one study.

Before you start to take Montelair


Tell your doctor if:
1. you are pregnant or intend to become pregnant
Montelair has not been studied in pregnant women.
2. you are breast-feeding or plan to breast-feed
It is not known if Montelair passes into breast milk.
3. you have or have had any medical conditions
4. your child has a condition called phenylketonuria
The 5 mg and 4 mg chewable tablets contain aspartame, corresponding to 1.5 mg phenylalanine in each 5 mg tablet and 1.2 mg in each 4 mg tablet.
5. you have any allergies to any other medicines or any other substances, such as foods, preservatives or dyes.
If you have not told your doctor about any of the above, tell them before you take any Montelair.

Taking other medicines


Some medicines may affect how Montelair works, or Montelair may affect how your other medicines work.
Tell your doctor if you are taking any other medicines, including medicines that you buy without a prescription from your pharmacy, supermarket or health food shop.

How to take it

How much to take


For patients with asthma and/or seasonal allergic rhinitis, take Montelair only when prescribed by your doctor.
For adults and teenagers 15 years and older, the dose is one 10 mg tablet taken each day.
For children 6 to 14 years old, the dose is one 5 mg chewable tablet taken each day.
For children 2 to 5 years old, the dose is one 4 mg chewable tablet taken each day.
For patients with asthma, take Montelair once a day in the evening.
For patients with seasonal allergic rhinitis, take Montelair once a day as prescribed by your doctor.
Follow all directions given to you by your doctor carefully.
They may differ from the information contained in this leaflet.
If you do not understand the instructions on the box, ask your doctor or pharmacist for help.

How to take it


Montelair comes as three types of tablets:
  • 10 mg tablets for adults and teenagers 15 years and older
  • 5 mg chewable tablets for children 6-14 years old
  • 4 mg chewable tablets for children 2-5 years old.

Swallow the 10 mg tablet with a glass of water.
Chew the 5 mg or 4 mg chewable tablets thoroughly and swallow.

When to take it


Asthma:
Take your Montelair at bedtime each day.
Taking your tablet at bedtime each day is expected to have the best effect. It will also help you remember when to take the tablets.
Seasonal allergic rhinitis:
Take your Montelair once a day as prescribed by your doctor.
Your doctor will advise you on the best time of the day to take your tablet.
Asthma and seasonal allergic rhinitis:
Take your Montelair at bedtime each day if you have both asthma and seasonal allergic rhinitis.
It does not matter if you take Montelair before or after food.

How long to take it


Montelair helps control your asthma. Therefore Montelair must be taken every day. Continue taking Montelair for as long as your doctor prescribes.

If you forget to take it


Skip the dose you missed and take your next dose as usual. Do not take a double dose to make up for the dose that you missed.
If you have trouble remembering to take your tablets, ask your pharmacist for some hints.

If you take too much (overdose)


Immediately telephone your doctor or Poisons Information Centre (telephone 13 11 26) for advice, if you think that you or anyone else may have taken too much Montelair. Do this even if there are no signs of discomfort or poisoning.
The most common symptoms reported with overdose in adults and children include thirst, sleepiness, dilated pupils, hyperactivity, and stomach pain.

While you are taking it

Things you must do


Continue taking Montelair everyday as directed by your doctor, even if you have no asthma symptoms or if you have an asthma attack.
If your asthma gets worse while taking Montelair, tell your doctor immediately.
If an acute attack of asthma occurs, follow your doctor's instructions on what reliever medicine to use to relieve the attack.
If you experience behaviour and mood-related changes while taking Montelair, tell your doctor immediately.
If you become pregnant while taking Montelair, tell your doctor immediately.
If you are about to be started on any new medicine, tell your doctor and pharmacist that you are taking Montelair.

Things you must not do


If you have been prescribed the 10 mg tablets, do not take two 5 mg chewable tablets in its place. If you have been prescribed the 5 mg tablets, do not take half a 10 mg tablet in its place.
The different strength tablets may not have the same effect, as they are absorbed slightly differently in the body.
Do not take Montelair to relieve an acute asthma attack. In case of an acute asthma attack, follow your doctor's instructions on what reliever medicine to use.
Do not give Montelair to anyone else, even if they have the same condition as you.

Side Effects


Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking Montelair.
Montelair helps most people with asthma and/or seasonal allergic rhinitis, but it may have unwanted side effects in a few people. All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects.
Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor if you notice any of the following and they worry you:

  • fluid retention
  • nose bleed
  • headache, dizziness, drowsiness
  • feeling unusually weak or tired
  • upper respiratory tract infection
  • bedwetting in children

muscle or nerve problems:
  • muscle aches or cramps, joint pain
  • decreased feeling or sensitivity, especially in the skin
  • pins and needles

stomach or bowel problems:
  • stomach pain
  • nausea, vomiting
  • diarrhoea

Behaviour and mood-related changes, including suicidal thoughts and actions, have been reported in patients taking montelukast. If you or your child experience these changes while taking montelukast, tell your doctor.
Tell your doctor if you notice any of the following behaviour and mood-related changes:
  • agitation, including aggressive behaviour and/or hostility
  • anxiousness, depression (sad moods)
  • disorientation, dream abnormalities, hallucinations (seeing or hearing things that are not there)
  • insomnia, irritability, restlessness, sleep walking
  • tremor
  • uncontrolled muscle movements
  • obsessive-compulsive symptoms.

These are usually mild side effects of Montelair.
Tell your doctor immediately if you notice any of the following:
  • suicidal thoughts and actions
  • skin rash or itchiness
  • increased tendency to bleed, bruising
  • fast or irregular heartbeats, also called palpitations
  • symptoms of liver disease such as nausea, vomiting, loss of appetite, feeling generally unwell, fever, itching, yellowing of the skin and eyes, and dark coloured urine

These may be serious side effects. You may need urgent medical attention. Serious side effects are rare.
If any of the following happen, stop taking Montelair and tell your doctor immediately or go to accident and emergency at your nearest hospital:
  • swelling of the face, lips, mouth, throat or tongue which may cause difficulty in breathing or swallowing
  • pinkish, itchy swellings on the skin, also called hives or nettlerash, severe skin reactions that may occur without warning
  • seizure

These may be serious side effects. If you have them, you may be having a serious allergic reaction to Montelair. You may need urgent medical attention.
These side effects are rare.
Other side effects not listed above may also occur in some patients.
Tell your doctor if you notice any other effects.

After taking Montelair

Storage


Keep your tablets in the blister pack until it is time to take them.
If you take the tablets out the blister pack they may not keep well.
Keep Montelair in a cool dry place, away from light, where the temperature stays below 25°C.
Do not store it or any other medicine in the bathroom or near a sink.
Do not leave it in the car or on window sills.
Heat and dampness can destroy some medicines.
Keep it where children cannot reach it.
A locked cupboard at least one and a-half metres above the ground is a good place to store medicines.

Disposal


If your doctor tells you to stop taking the tablets, or the tablets have passed their expiry date, ask your pharmacist what to do with any that are left over.

Product description

What it looks like


Montelair comes as three types of tablets:
  • 10 mg tablet (AUST R 184828) - Beige coloured, rounded square, biconvex, film coated tablet debossed “M10” on one side and plain on other side.
  • 5 mg chewable tablet (AUST R 184825) – Pink coloured, mottled, round, biconvex, uncoated tablet, debossed “M5” on one side and plain on other side.
  • 4 mg chewable tablet (AUST R 184837) - Pink coloured, mottled, oval, biconvex, uncoated tablet, debossed “M4” on one side and plain on other side.

A box of Montelair contains 14 or 28 tablets.
To start treatment, Montelair may also be supplied in packs of 4 tablets.

Ingredients


Active ingredient:
  • 10 mg tablet contains 10 mg Montelukast
  • 5 mg chewable tablet contains 5 mg montelukast
  • 4 mg chewable tablet contains 4 mg Montelukast

Inactive ingredients:


10 mg tablets
  • microcrystalline cellulose
  • lactose monohydrate
  • Microcelac 100
  • hyprolose
  • croscarmellose sodium
  • magnesium stearate
  • hypromellose
  • titanium dioxide
  • macrogol 6000
  • iron oxide red
  • iron oxide yellow

5 mg and 4 mg chewable tablets
  • mannitol
  • microcrystalline cellulose
  • croscarmellose sodium
  • aspartame
  • cherry flavour
  • iron oxide red
  • magnesium stearate

Montelair 10 mg tablets, and 5 mg and 4 mg chewable tablets do not contain gluten, sucrose, tartrazine or any other azo dyes.
The 10 mg tablets contain lactose; the 5 mg and 4 mg chewable tablets do not.

Name and Address of the Sponsor


Arrotex Pharmaceuticals Pty Ltd
15 – 17 Chapel Street
Cremorne VIC 3121
Australia

Date of most recent amendment:


January 2024

BRAND INFORMATION

Brand name

Montelair

Active ingredient

Montelukast

Schedule

S4

 

1 Name of Medicine

Montelukast (as sodium).

2 Qualitative and Quantitative Composition

Each Montelair 10 film coated tablet contains 10.4 mg montelukast sodium, which is equivalent to 10.0 mg of montelukast.
Each Montelair 5 chewable tablet contains 5.2 mg montelukast sodium, which is equivalent to 5.0 mg of montelukast.
Each Montelair 4 chewable tablet contains 4.16 mg montelukast sodium, which is equivalent to 4.0 mg of montelukast.
Excipients with known effect. Aspartame and mannitol in the 4 mg and 5 mg tablets only.
Lactose monohydrate in the 10 mg tablets only.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

Montelair 4 tablets. Pink coloured, mottled, oval, biconvex, uncoated tablet, debossed "M4" on one side and plain on other side.
Montelair 5 tablets. Pink coloured, mottled, round, biconvex, uncoated tablet, debossed "M5" on one side and plain on other side.
Montelair 10 tablets. Beige coloured, rounded square, biconvex, film coated tablet debossed "M10" on one side and plain on other side.

4 Clinical Particulars

4.9 Overdose

No specific information is available on the treatment of overdosage with montelukast. In chronic asthma studies, montelukast has been administered at doses up to 200 mg/day to adult patients for 22 weeks and in short-term studies, up to 900 mg/day to patients for approximately one week without clinically important adverse experiences.
There have been reports of acute overdosage in postmarketing experience and clinical studies with montelukast. These include reports in adults and children with a dose as high as 1000 mg. The clinical and laboratory findings observed were consistent with the safety profile in adults and paediatric patients.
There were no adverse experiences in the majority of overdosage reports.
The most frequently occurring adverse experiences were consistent with the safety profile of montelukast and included abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity.
It is not known whether montelukast is dialyzable by peritoneal or hemodialysis.
For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).

5 Pharmacological Properties

5.3 Preclinical Safety Data

Genotoxicity. Montelukast sodium was found not to be genotoxic. Montelukast sodium was negative in microbial and mammalian cell mutagenesis assays, with and without metabolic activation. There was no evidence of clastogenic activity in the in vitro chromosomal aberration assay in Chinese hamster ovary cells, with or without a microsomal enzyme activation system, or of DNA damage in the in vitro alkaline elution assay in rat hepatocytes. Similarly, there was no induction of chromosomal aberrations in bone marrow cells of male or female mice.
Carcinogenicity. Montelukast sodium was not carcinogenic when administered at oral doses of up to 200 mg/kg/day in 104 week study in rats, nor at oral doses up to 100 mg/kg/day in a 91 week study in mice. Systemic exposure in these studies, in terms of the plasma AUC for parent drug, was at least 30 times higher than that in humans at recommended dose levels.

6 Pharmaceutical Particulars

6.7 Physicochemical Properties

Montelukast sodium is a selective and orally active leukotriene receptor antagonist that specifically inhibits the cysteinyl leukotriene CysLT1-receptor.
Montelukast sodium is a hygroscopic, optically active, white to off white, free flowing powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. Montelukast is the optically active R-stereoisomer.
Chemical name: [R-(E)]-1-[[[1-[3-[2- (7-chloro-2- quinolinyl) ethenyl] phenyl]-3-[2- (1-hydroxy-1-methylethyl) phenyl] propyl] thio] methyl] cyclopropane acetic acid, monosodium salt. Molecular formula: C35H35ClNNaO3S. Molecular weight: 608.18.
Chemical structure.
https://stagingapi.mims.com/au/public/v2/images/fullchemgif/CSMONTSO.gif CAS number. 151767-02-1.

7 Medicine Schedule (Poisons Standard)

Prescription only Medicine (S4).

Summary Table of Changes

https://stagingapi.mims.com/au/public/v2/images/fulltablegif/MONTELST.gif